FindTrial
Sign In

Real world retrospective analysis of precise individualized comprehensive treatment for bone and soft tissue sarcoma

Real world retrospective analysis of precise individualized comprehensive treatment for bone and soft tissue sarcoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062395
Enrollment
Unknown
Registered
2022-08-04
Start date
2022-08-05
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bone and soft tissue sarcoma

Interventions

Individualized comprehensive treatment group:Individualized comprehensive treatment

Sponsors

Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age 15-85 years old, both genders; 2. ECOG score of 0-3 points; 3. Pathologically diagnosed bone and soft tissue sarcoma, the staging standard refers to the 8th edition of AJCC; 4. Has received precise individuals from our center The patient's diagnosis, treatment, follow-up review and other information are clearly recorded in the medical record system.

Exclusion criteria

Exclusion criteria: Incomplete data of patients affects the judgment of efficacy and safety

Design outcomes

Primary

MeasureTime frame
objective response rate;—

Secondary

MeasureTime frame
disease control rate;progression free survival;overall survival;—

Countries

China

Contacts

Public ContactXiaolu Wang
njwangxiaolu@163.com+8613813382590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026